|
 CANDRIAM EQUITIES L BIOTECHNOLOGY I USD CAP | | Umbrella Fund | Candriam Equities L | Currency | USD | Dates | | Promoter | Candriam Sca | Country | LUX | Inception | 04/03/2010 | | | Nature | SICAV | Closing | - | | EP Category | Equity biotechnology | ISIN | LU0133360163 | | Rating category | Equity biotechnology | Etoiles EuroPerformance |  |
|
|
| |
| Europerformance Categories | | | | | Ss Family : | Equity themes and sectors |
| | | | | | | | | | Cat : | Equity biotechnology |
|
| | |
|
|  | | NAV | | Date | 15/05/2024 | | VL | 5 628.34 | | Variation | 1.44 | | Currency | USD | | Net Assets (at the end of the month) | 28.002 (Million €) | | Total Net asset (subfund level)(end of month) | only to registered users |
|
| | | Evolution of the NAV |  |
|
|
| |
| Management | | Management company | Candriam Sca | | Custodian | Caceis Bank (Lux) | | | | | | Risk profile | | Accum. / Distri. | Accumulation | | Frequency | Daily | Frequency of the dividends | | | Geographical investment zone | World | Max. management fees | 0.75% |
|
| | | Marketing countries | | Distributed AUT |  | | Distributed CHE | | | Distributed DEU | | | Distributed ESP | | | Distributed FRA | | | Distributed GBR | | | Distributed ITA | | | Distributed LUX | | | Distributed NLD | |
|
| | | | | | Accumulation fund | |
|
|
|
|
| Subscription / Redemption | | Subscription fees | Redemption fees | | Min / Max | Fixed 0.00 % | Min / Max | Fixed 0.00 % | | dedicated to the fund | - | dedicated to the fund | - | | Subscription | Unknown price | Redemption | Unknown price | | Recommended minimum investment period | At least 72 Month |
|
|
|
|
|
|
|
|
